|
|
|
|
 |
| June 23,
2011 | ISSUE NUMBER 205 VOL 8 |
R&D
Does Six Sigma Stifle R&D Innovation?
Can the management style known as Six Sigma help improve the probability of a drug's commercial success, or does it punch holes in the creative process needed for innovative R&D discovery? ...Read more
Patient Education
Treatment TV
New disease-specific television networks shown in physicians' offices provide education for patients and advertising at the point of contact for pharma companies. ...Read more
| Advertisement |
| |
| |
 |
| |
| |
| |
|
Critical Path Decisions for the 4 C's in Life Sciences
Streamline production, increase cash flow, and minimize risk in your Order to Cash, Contracts, Chargebacks and Compliance processes. Owens Minor Healthcare Logistics and CDC Software address the pains, the capabilities needed and results possible in these 4 "C" processes. Looking to upgrade your business solution? Get tips for making your buy, subscribe or outsourcing decision.
 Watch Now |
Biologics
Can Biotech Follow Big Pharma?
Big Pharma companies that have not yet acquired biopharmaceuticals firms are still considering doing so. But not all biologics companies are living large, as data from Ernst & Young remind us. ...Read more
| Advertisement |
| |
| |
|
| |
| |
| |
| |
|
Take Control of Your Contracts and Chargebacks Now
New products, growing partner base, high transaction volumes and stringent data accuracy requirements can make managing contracts and chargebacks extremely difficult. Discover how an integrated, automated contracts and chargebacks solution can positively impact sales, operations, purchasing, accounting and customer service. By eliminating unauthorized deductions, minimizing revenue losses and reducing manpower, you can focus on growing your business.
 Read White Paper |
Global
Are You Ready for the New China?
Foreign investors need the wiles of a tigress as the government revisits the idea of private healthcare. ...Read more
Advertisement
Pharm Exec's Top 50 Pharma Companies
Is the recent wave of megamergers enough to counter a looming storm surge of patent expirations? Find out in our annual Pharm Exec 50, which ranks the world's largest pharmaceutical companies by global sales of prescription drugs—a key indicator of market change. See who’s in, who’s out, and who emerged on top……
 Read more
|
|
|
|
 // Bob Jansen and Michelle Woker have been named Co-Presidents of Wolters Kluwer Pharma Solutions' (Bridgewater, N.J.) healthcare analytics business. Both leaders were promoted from within the company and will report directly to Bob Becker, President and CEO. // Biopharm company Endocyte (West Lafayette, Ind.) announced the appointment of Binh Nguyen, M.D., Ph.D. as Vice President of Clinical Affairs. //
Generex Biotechnology (Worcester, Mass.) tapped Jos van der Woert as Chief Executive Officer of its wholly owned subsidiary, Antigen Express, following its spinout. //
Akshay Vaishnaw has been promoted to Chief Medical Officer of Alnylam (Cambridge, Mass.) from his role as Vice President of Clinical Research. //
ERT (Philadelphia), a global provider of clinical services and customizable medical devices, appointed Robert Kleiman, MD as Chief Medical Officer. //
|
Educational Video:
Improving Clinical Operations with Digital Signatures
The majority of large CROs and Pharmas are using digital signatures to speed clinical site initiation, reduce site monitoring reporting costs, and improve audit efficiency.  Watch this short video to learn how digital signatures enable these benefits and others. |
 |
|
|
|
|
|
|
 |
|
| |
|
| |
|
| |
|
 |
|
 |
| Do you think it is essential that pharma CEOs come from a scientific background? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
